Update on the merger with Magle Group

28 June 2024

We are very happy to inform that a merger agreement between pK Chemicals and Magle Chemoswed Holding AB ("Magle Group") has been signed.

The merger will combine resources and expertise, unlocking new growth opportunities and achieving operational efficiencies. The new Magle Group will offer an extensive portfolio covering technical Dextran, Dextran Derivatives, DSM-based innovations, active pharmaceutical ingredients, and customized solutions for the pharmaceutical and medico sectors.

The deal is expected to be completed in July 2024.

Morten Bergstrand, CEO of pKC, commented: “Becoming part of the Magle Group is a fantastic opportunity for pKC. The combination of our production capabilities and expertise and Magle’s state of the art innovation and product development competences is a perfect match. This is a great step forward for pKC’s customers, employees and owners.”